Verification evidence is still being completed.
PDF / print export
Biognosys
Schlieren, Switzerland
- Verified lead
- Oliver Rinner
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer and Co-Founder
- 2026 technical specialization
- Proteomics, Translational Research, Clinical Proteomics, Biomarker Discovery, and Life Science Tools
- Review cycle
- May 2026
- Full address
- Wagistrasse 21, 8952 Schlieren, Switzerland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Biognosys contact page confirming the Schlieren address.
- Editorial note
- Biognosys is published because official company materials confirm current leadership, Schlieren operating address, and a real translational-proteomics platform.
Proteomics, Translational Research, Clinical Proteomics, Biomarker Discovery, and Life Science Tools
Official leadership disclosure, Official Schlieren address disclosure, Proteomics platform claim
Biognosys is published because official company materials confirm current leadership, Schlieren operating address, and a real translational-proteomics platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Schlieren, Switzerland
Biognosys
Proteomics, Translational Research, Clinical Proteomics, Biomarker Discovery, and Life Science Tools · Global proteomics platform
Biognosys runs proteomics services, biomarker discovery, and translational and clinical workflow support in Schlieren, Switzerland.
- Lead
- Oliver Rinner (verified ↗)
- Address
- Wagistrasse 21, 8952 Schlieren, Switzerland (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Global proteomics platform
- Capabilities
- Proteomics Services · Biomarker Discovery · Translational and Clinical Workflow Support
- Founded
- 2008
- Headcount
- 51-200
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Oliver Rinner
Chief Executive Officer and Co-Founder
Full addressWagistrasse 21, 8952 Schlieren, Switzerland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Global proteomics platform
Schlieren, Switzerland. Proteomics, Translational Research, Clinical Proteomics, Biomarker Discovery, and Life Science Tools. Review completed on 22 Mar 2026.
Swiss corporate and life-science tools oversight
Official leadership disclosure, Official Schlieren address disclosure, Proteomics platform claim
Proteomics, Translational Research, Clinical Proteomics, Biomarker Discovery, and Life Science Tools
Biognosys is published because official company materials confirm current leadership, Schlieren operating address, and a real translational-proteomics platform.
Editorial note
Biognosys is published because official company materials confirm current leadership, Schlieren operating address, and a real translational-proteomics platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Proteomics Services
Biomarker Discovery
Translational and Clinical Workflow Support
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Proteomics workflow systems
Biomarker-analysis infrastructure
Clinical and translational support tools
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Biognosys located?
- Biognosys operates from Wagistrasse 21, 8952 Schlieren, Switzerland, Schlieren, Switzerland.
- Who runs Biognosys?
- Biognosys is led by Oliver Rinner, Chief Executive Officer and Co-Founder. Verified 22 Mar 2026.
- What does Biognosys do?
- Biognosys runs proteomics services, biomarker discovery, and translational and clinical workflow support in Schlieren, Switzerland. Core capabilities: Proteomics Services, Biomarker Discovery, Translational and Clinical Workflow Support.
Editorial context
Related technical briefs
Briefs that name Schlieren as a covered market or city.